Findings were based on a portable monitor and use of a semi-automatic treatment algorithm.
Continuous positive airway pressure (CPAP) remains the mainstay of medical treatment for OSA.
Sleep quality in patients with chronic obstructive pulmonary disease may be a significant predictor of multiple metrics of quality of life.
To examine the link between cardiovascular disease and sleep apnea, The Cardiology Advisor spoke with cardiologist Seth S. Martin, MD, MHS, FACC, FAHA and sleep specialist Rachel Marie E. Salas, MD, FAAN.
Pediatric patients with hypertension and obstructive sleep apnea had significant improvements in blood pressure after adenotonsillectomy.
Severe sleep disordered breathing was associated with elevated arterial stiffness and may be related to the pathophysiology of heart failure, particularly in patients with preserved ejection fraction.
Patients with obstructive sleep apnea had higher rates of hospital readmission when not adherent to continuous positive airway pressure therapy.
Prior authorizations for medications and diagnostic imaging continue to be a source of frustration for providers.
Oronasal masks may not be as effective as nasal masks for the treatment of obstructive sleep apnea.
Non-sleep specialists and sleep specialist physicians provide similar quality care with similar patient outcomes for adults with OSA.
Patients with sleep apnea may have a higher risk for recurrent stroke and death.
A new 14-year analysis indicate that adults are getting more sleep each night despite the prevalence of sleep duration among Americans.
A middle-aged man diagnosed with COPD presents with shortness of breath at rest with no improvement with nebulizer treatments.
Moderate to severe obstructive sleep apnea is relatively common in individuals with major depression.
Dronabinol may be an effective treatment in adults with obstructive sleep apnea.
Obstructive sleep apenea may increase the amyloid burden in cognitively normal older patients.
Bariatric surgery and continuous positive airway pressure were directly compared as initial treatment modalities for obstructive sleep apnea.
Home sleep apnea tests are a less expensive alternative to polysomnography tests in detecting obstructive sleep apnea.
Patients with severe obstructive sleep apnea who use continuous positive airway pressure therapy may experience a decrease in carotid intima-media thickness.
Participants received web-based OSA education, CPAP telemonitoring with automated feedback, both, or usual care.
Patients identified as having high-risk obstructive sleep apnea by the STOP-Bang Questionnaire were more likely to have postoperative complications and longer hospital stays.
Data from 200 participants were analyzed to determinet he link between sleep disordered breathing, cognitive function, and cognitive impairment.
Patients with severe obstructive sleep apnea appear to have a higher risk for hypercoagulability, which can contribute to cardiovascular complications.
The automatically estimated apnea-hypopnea index showed high agreement with AHI measured with conventional nocturnal polysomnography.
Adverse events and renal function were monitored in patients receiving CPAP and those receiving usual care.
In patients with mild cognitive impairment, there is an association between obstructive sleep apnea and beta-amyloid levels.
Watching a tape of themselves struggling to sleep increases CPAP adherence in patients with OSA.
Researchers simultaneously examined overnight polysomnography and patch recordings to determine the efficacy of the SomnaPatch.
Nearly 37% of patients with hypoventilation were diagnosed with uncontrolled hypothyroidism, and were more likely to present with hypertension and heart failure.
Treatment with CPAP doesn't doesn't reduce risk of cardiovascular related outcomes.
Apnea-hypopnea index concluded that hematocrit levels and presene of erthrocytosis are not associated with OSA.
A patient developed Stevens-Johnson Syndrome following armodafinil therapy for daytime sleepiness.
It is unknown what the clinical impact of positive airway pressure in patients with pulmonary embolism
OSA is associated with sight-threatening diabetic retinopathy in patients with type 2 diabetes; preliminary evidence suggests CPAP reduces retinopathy.
Research presented at SLEEP 2017 suggests that dronabinol, previously used to treat chemotherapy-induced nausea and vomiting, may be an effective treatment for sleep apnea.
From 1993 to 2011 there is an increased number of documented visits for SA by specials and a decreased number of visits by primary care providers.
Three in 4 study participants had sleep apnea, but only 2.1% of those cases were diagnosed.
Risk for serious pregnancy complications, length of hospital stay, and intensive care unit admission are higher in in women with obstructive sleep apnea.
Obstructive sleep apnea increases patients' risk for recurrent pulmonary embolism following cessation of oral anticoagulation therapy.
Two studies examined the link between open-heart surgery and postoperative atrial fibrillation.
The American Heart Association panel found that sleep disorders are associated with adverse cardiometabolic risk profiles and outcomes.
Although patients in the CPAP group experienced improvements in quality of life, the therapy had no significant effects on the composite end point of death from any cardiovascular cause, MI, stroke, or hospitalization for various cardiovascular events.